Search results
AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids
Zacks via Yahoo Finance· 4 weeks agoAstraZeneca AZN announced that the FDA has approved its marketed asthma drug, Fasenra...
The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker...
Zacks via Yahoo Finance· 20 hours agoFor Immediate Release Chicago, IL – May 6, 2024 – Zacks.com announces the list of stocks featured in...
AstraZeneca's Fasenra Flunks Late-Stage Trial In Patients With Esophagus Inflammation
Benzinga via Yahoo Finance· 2 years agoAstraZeneca Plc (NASDAQ: AZN) has reported topline data from the MESSINA Phase 3 trial Fasenra...
AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Pharmaceutical Technology via Yahoo Finance· 1 week agoAstraZeneca has recently announced that Fasenra has been approved for severe asthma, specifically...
AstraZeneca (AZN) Key Drugs to Aid Growth, Pipeline Strong
Zacks via Yahoo Finance· 7 months agoAstraZeneca's (AZN) key drugs like Lynparza, Tagrisso, Fasenra and Farxiga should keep driving...
AstraZeneca (AZN) Q2 Earnings & Sales Beat, Nil COVID Sales
Zacks via Yahoo Finance· 9 months agoAstraZeneca (AZN) beats second-quarter estimates for earnings and sales. The company did not...
AstraZeneca (AZN) Q4 Earnings & Sales Miss Estimates, Stock Down
Zacks via Yahoo Finance· 3 months agoAstraZeneca (AZN) marginally misses fourth-quarter estimates for earnings and sales. It expects...
AstraZeneca (AZN) Q1 Earnings Beat, COVID Products Hurt Sales
Zacks via Yahoo Finance· 1 year agoAstraZeneca’s AZN first-quarter 2023 core earnings of 96 cents per American depositary share (ADS)...
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
Zacks via Yahoo Finance· 6 months agoAstraZeneca’s AZN third-quarter 2023 core earnings of 87 cents per American depositary share (ADS)...
AstraZeneca's (AZN) Q3 Earnings Beat, EPS Growth View Up
Zacks via Yahoo Finance· 1 year agoAstraZeneca (AZN) beats third-quarter estimates for earnings while sales come in line. AZN raises...